Latest news

Filters
August 16, 2005

Debiopharm and DeveloGen announce partnering of myasthenia gravis program

Read more
June 27, 2005

Debiopharm and Neovacs sign License and Equity Agreement for the development fo Neovacs´ anti-TNF-Alpha product

Read more
May 11, 2005

Debiopharm announces marketing and supply agreement for Trelstar® in Canada

Read more
April 21, 2005

Debiopharm and NanoCarrier form Research Collaboration on a new platinum compound using the Medicelle TM technology

Read more
March 30, 2005

Debiopharm S.A. invests in NanoCarrier Mezzanine Funding Round

Read more
March 21, 2005

Debiopharm announces import approval from Elplat® (Oxaliplatin) in Japan

Read more
March 1, 2005

Debiopharm S.A. announces the purchase of all outstanding shares of H3 Pharma

Read more
February 7, 2005

Debiopharm S.A. announces marketing approval for a new formulation of Eloxatin® (Oxaliplatin for injection)

Read more
January 4, 2005

H3 Pharma receives approvable letter from FDA for Sanvar® for esophageal variceal bleeding

Read more